Alector doses first patient in Alzheimer’s trial for new therapy
Alector - 08-Feb-2024Al101 shows promise in boosting brain health for early Alzheimer’s patients
GlaxoSmithKline (GSK)
Research and develop pharmaceutical medicines, vaccines and consumer healthcare products
British multinational pharmaceutical company headquartered in London. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, GSK was the world's seventh largest pharmaceutical company as of 2015.
Its biggest-selling products in 2013 were Advair, Avodart, Flovent, Augmentin, Lovaza, and Lamictal.
Four GlaxoSmithKline scientists have been recognized by the Nobel Committee for their contributions to basic medical science and/or therapeutics development.
Visit website: https://www.gsk.com/
Details last updated 27-Dec-2019
GlaxoSmithKline (GSK) News
23andMe discover new gene loci for 3 rare diseases
GenomeWeb - 20-Oct-2021Demonstrates the power of having millions of DNA records even with less reliable self-reported data
GSK and Alector collaborate on Alzheimer’s and Parkinson’s treatments
Fortune - 02-Jul-2021The $2.2 billion deal will focus on immune-based therapies for neurodegenerative diseases
GSK on artificial intelligence drive to develop drugs faster
Guardian - 25-Dec-2019The more people looking at clever new ways to beat cancer the better
Scientists uncover the secret behind cancer cell's immortality
Medical Xpress - 10-Sep-2018Doesn't seem to harm normal cells unlike telomerase blocking drugs that are too toxic
Display all news
GlaxoSmithKline (GSK) Blog Posts
24-May-2018
Empire State of Mind (and Body)
manipulation over the Opportunities opened up with human genetic engineering need to be regulated global to avoid exploitation
People at GlaxoSmithKline (GSK)
Topics mentioned on this page:
Big Pharma
